Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial.

Schnuelle P, Gottmann U, Hoeger S, Boesebeck D, Lauchart W, Weiss C, Fischereder M, Jauch KW, Heemann U, Zeier M, Hugo C, Pisarski P, Krämer BK, Lopau K, Rahmel A, Benck U, Birck R, Yard BA.

JAMA. 2009 Sep 9;302(10):1067-75. doi: 10.1001/jama.2009.1310.

PMID:
19738091
2.

Donor desmopressin is associated with superior graft survival after kidney transplantation.

Benck U, Gottmann U, Hoeger S, Lammert A, Rose D, Boesebeck D, Lauchart W, Birck R, Weiss C, Krämer BK, Yard BA, Schnuelle P.

Transplantation. 2011 Dec 15;92(11):1252-8. doi: 10.1097/TP.0b013e318236cd4c.

PMID:
22067309
3.

Effects of donor pre-treatment with dopamine on survival after heart transplantation: a cohort study of heart transplant recipients nested in a randomized controlled multicenter trial.

Benck U, Hoeger S, Brinkkoetter PT, Gottmann U, Doenmez D, Boesebeck D, Lauchart W, Gummert J, Karck M, Lehmkuhl HB, Bittner HB, Zuckermann A, Wagner F, Schulz U, Koch A, Bigdeli AK, Bara C, Hirt S, Berchtold-Herz M, Brose S, Herold U, Boehm J, Welp H, Strecker T, Doesch A, Birck R, Krämer BK, Yard BA, Schnuelle P.

J Am Coll Cardiol. 2011 Oct 18;58(17):1768-77. doi: 10.1016/j.jacc.2011.05.060.

4.

Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trial.

Orban JC, Quintard H, Cassuto E, Jambou P, Samat-Long C, Ichai C.

Transplantation. 2015 Apr;99(4):746-53. doi: 10.1097/TP.0000000000000395.

5.

Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial.

Kainz A, Wilflingseder J, Mitterbauer C, Haller M, Burghuber C, Perco P, Langer RM, Heinze G, Oberbauer R.

Ann Intern Med. 2010 Aug 17;153(4):222-30. doi: 10.7326/0003-4819-153-4-201008170-00003.

PMID:
20713790
6.

Donor dopamine pretreatment and graft function after kidney transplantation.

Ridgway D, Barrie J, Menon K.

JAMA. 2010 Jan 20;303(3):230-1; author reply 231-2. doi: 10.1001/jama.2009.1995. No abstract available.

PMID:
20085949
7.

Donor dopamine pretreatment and graft function after kidney transplantation.

Ball J, McAnulty G.

JAMA. 2010 Jan 20;303(3):231; author reply 231-2. doi: 10.1001/jama.2009.1996. No abstract available.

PMID:
20085948
8.

Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation.

Schnuelle P, Lorenz D, Mueller A, Trede M, Van Der Woude FJ.

Kidney Int. 1999 Aug;56(2):738-46.

9.

Influence of donor pretreatment with dopamine on allogeneic kidney transplantation after prolonged cold storage in rats.

Gottmann U, Notheisen A, Brinkkoetter PT, Yard BA, Waldherr R, Schnuelle P, van der Woude FJ, Braun C.

Transplantation. 2005 May 27;79(10):1344-50.

PMID:
15912102
10.

Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study.

Summers DM, Johnson RJ, Hudson A, Collett D, Watson CJ, Bradley JA.

Lancet. 2013 Mar 2;381(9868):727-34. doi: 10.1016/S0140-6736(12)61685-7. Epub 2012 Dec 20.

PMID:
23261146
11.

Outcomes of kidney transplants from non-heart-beating deceased donors as reported to the Japan Organ Transplant Network from April 1995-December 2003: a multi-center report.

Teraoka S, Nomoto K, Kikuchi K, Hirano T, Satomi S, Hasegawa A, Uchida K, Akiyama T, Tanaka S, Babazona T, Shindo K, Nakamura N.

Clin Transpl. 2004:91-102.

PMID:
16704141
12.

Effects of Dopamine Donor Pretreatment on Graft Survival after Kidney Transplantation: A Randomized Trial.

Schnuelle P, Schmitt WH, Weiss C, Habicht A, Renders L, Zeier M, Drüschler F, Heller K, Pisarski P, Banas B, Krämer BK, Jung M, Lopau K, Olbricht CJ, Weihprecht H, Schenker P, De Fijter JW, Yard BA, Benck U.

Clin J Am Soc Nephrol. 2017 Mar 7;12(3):493-501. doi: 10.2215/CJN.07600716. Epub 2017 Feb 17.

PMID:
28213388
13.

Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data.

Bresnahan BA, McBride MA, Cherikh WS, Hariharan S.

Transplantation. 2001 Jul 27;72(2):256-61.

PMID:
11477349
14.
15.

Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study.

Summers DM, Johnson RJ, Allen J, Fuggle SV, Collett D, Watson CJ, Bradley JA.

Lancet. 2010 Oct 16;376(9749):1303-11. doi: 10.1016/S0140-6736(10)60827-6. Epub 2010 Aug 18.

PMID:
20727576
16.

Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.

Pérez-Flores I, Sánchez-Fructuoso A, Calvo N, Marques M, Anaya S, Ridao N, Rodríguez A, Barrientos A.

Transplant Proc. 2007 Sep;39(7):2123-4.

PMID:
17889112
17.

Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function.

Niemann CU, Feiner J, Swain S, Bunting S, Friedman M, Crutchfield M, Broglio K, Hirose R, Roberts JP, Malinoski D.

N Engl J Med. 2015 Jul 30;373(5):405-14. doi: 10.1056/NEJMoa1501969.

18.

When should expanded criteria donor kidneys be used for single versus dual kidney transplants?

Alfrey EJ, Lee CM, Scandling JD, Pavlakis M, Markezich AJ, Dafoe DC.

Transplantation. 1997 Oct 27;64(8):1142-6.

PMID:
9355831
20.

Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins.

de Boer J, De Meester J, Smits JM, Groenewoud AF, Bok A, van der Velde O, Doxiadis II, Persijn GG.

Transpl Int. 1999;12(6):447-53.

Supplemental Content

Support Center